These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19110543)

  • 1. Drug-virus interaction: effect of administration of recombinant adenoviruses on the pharmacokinetics of docetaxel in a rat model.
    Wonganan P; Zamboni WC; Strychor S; Dekker JD; Croyle MA
    Cancer Gene Ther; 2009 May; 16(5):405-14. PubMed ID: 19110543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and macromolecular alterations of recombinant adenoviral vectors do not resolve changes in hepatic drug metabolism during infection.
    Callahan SM; Wonganan P; Croyle MA
    Virol J; 2008 Sep; 5():111. PubMed ID: 18826641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of transgene expression on drug metabolism following systemic adenoviral vector administration.
    Callahan SM; Boquet MP; Ming X; Brunner LJ; Croyle MA
    J Gene Med; 2006 May; 8(5):566-76. PubMed ID: 16508909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cytochrome P450 3A4 inhibition on the pharmacokinetics of docetaxel.
    Engels FK; Ten Tije AJ; Baker SD; Lee CK; Loos WJ; Vulto AG; Verweij J; Sparreboom A
    Clin Pharmacol Ther; 2004 May; 75(5):448-54. PubMed ID: 15116057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of granisetron on the pharmacokinetics and pharmacodynamics of docetaxel in Asian lung cancer patients.
    Miyata M; Yasuda K; Burioka N; Takane H; Suyama H; Shigeoka Y; Endo M; Kurai J; Morita M; Igishi T; Shimizu E
    Cancer J; 2006; 12(1):69-72. PubMed ID: 16613665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased activity of CYP3A enzyme in primary cultures of rat hepatocytes treated with docetaxel: comparative evaluation with paclitaxel.
    Nallani SC; Genter MB; Desai PB
    Cancer Chemother Pharmacol; 2001 Aug; 48(2):115-22. PubMed ID: 11561777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of triacontanol on the pharmacokinetics of docetaxel in rats associated with induction of cytochrome P450 3A1/2.
    Deng S; Wang C; Zhang W; Gao W; Fan A; Zhang Q; Zhang Y; Liu Q; Li N; Liu Q; Zhao J; Li C; Wen X; Zhao D; Chen X
    Xenobiotica; 2014 Jul; 44(7):583-90. PubMed ID: 24329500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of method of systemic administration of adenovirus on virus-mediated toxicity: focus on mortality, virus distribution, and drug metabolism.
    Boquet MP; Wonganan P; Dekker JD; Croyle MA
    J Pharmacol Toxicol Methods; 2008; 58(3):222-32. PubMed ID: 18723098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies.
    Goh BC; Lee SC; Wang LZ; Fan L; Guo JY; Lamba J; Schuetz E; Lim R; Lim HL; Ong AB; Lee HS
    J Clin Oncol; 2002 Sep; 20(17):3683-90. PubMed ID: 12202670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
    Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
    Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients.
    Nygren P; Hande K; Petty KJ; Fedgchin M; van Dyck K; Majumdar A; Panebianco D; de Smet M; Ahmed T; Murphy MG; Gottesdiener KM; Cocquyt V; van Belle S
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):609-16. PubMed ID: 15723220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense strategies for redirection of drug metabolism: using paclitaxel as a model.
    Arora V
    Methods Mol Med; 2005; 106():273-92. PubMed ID: 15375322
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of high-dose ketoconazole on the pharmacokinetics of docetaxel.
    Engels FK; Mathot RA; Loos WJ; van Schaik RH; Verweij J
    Cancer Biol Ther; 2006 Jul; 5(7):833-9. PubMed ID: 16775418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel.
    Paolini M; Poul L; Berjaud C; Germain M; Darmon A; Bergère M; Pottier A; Levy L; Vibert E
    Int J Nanomedicine; 2017; 12():5537-5556. PubMed ID: 28814868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and toxicity of docetaxel: role of CYP3A, MDR1, and GST polymorphisms.
    Tran A; Jullien V; Alexandre J; Rey E; Rabillon F; Girre V; Dieras V; Pons G; Goldwasser F; Tréluyer JM
    Clin Pharmacol Ther; 2006 Jun; 79(6):570-80. PubMed ID: 16765145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a newly developed ketolide antibiotic, telithromycin, on metabolism of theophylline and expression of cytochrome P450 in rats.
    Nosaka H; Nadai M; Kato M; Yasui K; Yoshizumi H; Miyoshi M; Zhao YL; Baba K; Takagi K; Hasegawa T
    Life Sci; 2006 May; 79(1):50-6. PubMed ID: 16423372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of docetaxel.
    Clarke SJ; Rivory LP
    Clin Pharmacokinet; 1999 Feb; 36(2):99-114. PubMed ID: 10092957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between docetaxel clearance and estimated cytochrome P450 activity by urinary metabolite of exogenous cortisol.
    Yamamoto N; Tamura T; Kamiya Y; Sekine I; Kunitoh H; Saijo N
    J Clin Oncol; 2000 Jun; 18(11):2301-8. PubMed ID: 10829051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Castration-dependent pharmacokinetics of docetaxel in patients with prostate cancer.
    Franke RM; Carducci MA; Rudek MA; Baker SD; Sparreboom A
    J Clin Oncol; 2010 Oct; 28(30):4562-7. PubMed ID: 20855838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of morin on the pharmacokinetics of docetaxel in rats with 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumors.
    Yang SH; Lee JH; Lee DY; Lee MG; Lyuk KC; Kim SH
    Arch Pharm Res; 2011 Oct; 34(10):1729-34. PubMed ID: 22076773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.